Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions like ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
3h
Axios Vitals on MSNFDA OKs adaptive brain pacemaker for Parkinson's treatmentThe Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...
A UC San Diego-led team's project to develop next-generation brain implants builds on the development of this transparent ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
15h
Hosted on MSNFDA Approves Adaptive Deep Brain Stimulator for Parkinson's DiseaseThe FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results